Compass Pathways Plc (CMPS) Q4 2022 Earnings Call Transcript
CMPS earnings call for the period ending December 31, 2022.
Stay updated with breaking news from Guy Goodwin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CMPS earnings call for the period ending December 31, 2022.
Guy Goodwin of COMPASS Pathways, explores the potential of tryptamines / psilocybin therapy in treatment resistant depression.
Mental health care company COMPASS Pathways plc (NASDAQ:CMPS) has announced positive data demonstrating the potential of its proprietary synthetic...
Investegate announcements from COMPASS Pathways, COMP360 psilocybin therapy shows potential in open-label study in type II bipolar disorder presented at ACNP
12 out of 14 patients went into remission for three months following a single 25mg dose of COMP360 psilocybin therapy, in an independent investigator-initiated, exploratory open-label study of type II